iShares Biotechnology ETF
IBB
IBB
463 hedge funds and large institutions have $4.63B invested in iShares Biotechnology ETF in 2016 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 146 increasing their positions, 137 reducing their positions, and 44 closing their positions.
Holders
463
Holders Change
+35
Holders Change %
+8.18%
% of All Funds
12.37%
Holding in Top 10
25
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+25%
% of All Funds
0.67%
New
87
Increased
146
Reduced
137
Closed
44
Calls
$650M
Puts
$1.24B
Net Calls
-$586M
Net Calls Change
+$176M
Top Buyers
| 1 |
1
Citigroup
New York
|
$627M |
| 2 |
2
Morgan Stanley
New York
|
$392M |
| 3 |
3
AllianceBernstein
Nashville,
Tennessee
|
$87.2M |
| 4 |
CI
4
Clal Insurance
Tel-Aviv,
Israel
|
$66.3M |
| 5 |
MIFH
5
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
$51.9M |
